These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16670529)

  • 1. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
    Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
    Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis.
    Wildt S; Nordgaard I; Hansen U; Brockmann E; Rumessen JJ
    J Crohns Colitis; 2011 Apr; 5(2):115-21. PubMed ID: 21453880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
    J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
    Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
    Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
    Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
    Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
    J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of probiotics after colonoscopy.
    D'Souza B; Slack T; Wong SW; Lam F; Muhlmann M; Koestenbauer J; Dark J; Newstead G
    ANZ J Surg; 2017 Sep; 87(9):E65-E69. PubMed ID: 26183594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
    Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
    J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
    Klein A; Friedrich U; Vogelsang H; Jahreis G
    Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Martoni CJ; Srivastava S; Leyer GJ
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
    Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
    Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
    Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
    Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
    J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
    Tavasoli S; Jalali S; Naji M; Borumandnia N; Shakiba Majd G; Basiri A; Khosravi Darani K; Karamad D; Tajabadi-Ebrahimi M; Taheri M
    Urol J; 2021 Jun; 19(3):179-188. PubMed ID: 34129232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
    West NP; Horn PL; Pyne DB; Gebski VJ; Lahtinen SJ; Fricker PA; Cripps AW
    Clin Nutr; 2014 Aug; 33(4):581-7. PubMed ID: 24268677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
    Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
    Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.